Empowering Patients through Technology to Manage and Track Symptoms of MS
Background: Symptom management, an important component of MS care, can be achieved by using a patient app tool to manage symptoms and...
Virtual I Can Do It Program for Individuals with Progressed Multiple Sclerosis
Background: The I Can Do It, You Can Do It (ICDI) national model was initiated by the U.S. department of Health and Human Services Office...
A Real-World Study Characterizing Symptoms and Impacts of Fatigue in US Adults with Relapsing Multiple Sclerosis Using a Novel Disease Specific Scale
Background: Fatigue is among the most frequent and disabling symptoms in RMS patients. Objectives: To measure multiple sclerosis (MS)...
Factors Associated with Stigma in People with Multiple Sclerosis.
Background: Social stigma is a common experience among persons with multiple sclerosis (PwMS), and it may impact daily functioning, quality...
Assessing the Impact of Disease Activity and Fatigue Symptom on Work Productivity and Activity Impairment in Patients with Relapsing Multiple Sclerosis
Background: Multiple Sclerosis (MS) is well known to reduce work productivity and adversely affect usual activities. Although previous...
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis
Background: Employers offer a variety of absence benefits. It is unknown how benefit design impacts the use of the benefits, the length of...
The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care
Background: Johns Hopkins Specialty Pharmacy provides clinical services for eligible multiple sclerosis (MS) patients on oral and...
Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis
Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...